Drugs / 18F-DTBZ
18F-DTBZ
also known as
18F-AV-133 · 18F-FP-DTBZ · AV-133 F-18 · Dtbz f-18 · Florbenazina (18f) · Florbenazine (18f) · FLORBENAZINE F 18
Trials 10 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01710371 | Dec 2012 → Sep 2015 | type 2 diabetes mellitus | Avid Radiopharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT01515384 | Jun 2010 → Feb 2013 | type 1 diabetes mellitus, type 2 diabetes mellitus | Avid Radiopharmaceuticals | Terminated | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01503944 | Mar 2010 → Jul 2011 | Alzheimer disease, Lewy body dementia, Parkinson disease | Avid Radiopharmaceuticals | Completed | No outcome recorded |
| Phase 26 trials | ||||||
| Phase 2 | NCT02599753 | Aug 2015 → Jul 2018 | Parkinson disease | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02195154 | Nov 2013 → Jul 2017 | vascular parkinsonism | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02059733 | Feb 2013 → Jul 2018 | Parkinson disease | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02039024 | Mar 2012 → Dec 2015 | Parkinson disease | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01759888 | Aug 2011 → Dec 2014 | Parkinson disease | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01283347 | May 2010 → Apr 2012 | Parkinson disease | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT01550484 | Apr 2012 → Mar 2016 | Lewy body dementia, Parkinson disease | Avid Radiopharmaceuticals | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F- DTBZ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02039024 ↗ |
| Known as | 18F-AV-133 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01550484 ↗ |
| Known as | 18F-FP-DTBZ | “Quantitative PET Imaging of Pancreatic Beta-Cell Mass in Healthy Overweight/Obese Subjects, Subjects With Prediabetes, and Type 2 Diabetes Patients With 18F-FP-DTBZ (18F-AV-133)” NCT01710371 ↗ |
| Known as | AV-133 F-18 | ChEMBL registry synonym — accepted as the source's own label CHEMBL579217 ↗ |
| Known as | Dtbz f-18 | ChEMBL registry synonym — accepted as the source's own label CHEMBL579217 ↗ |
| Known as | Florbenazina (18f) | ChEMBL registry synonym — accepted as the source's own label CHEMBL579217 ↗ |
| Known as | Florbenazine (18f) | ChEMBL registry synonym — accepted as the source's own label CHEMBL579217 ↗ |
| Known as | FLORBENAZINE F 18 | ChEMBL registry synonym — accepted as the source's own label CHEMBL579217 ↗ |
| Modality | Diagnostic / imaging agent | “18F-DTBZ PET” NCT01283347 ↗ |
| Route | Intravenous | “single i.v. administration” NCT01283347 ↗ |